Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer
NCT00582634
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
docetaxel and cisplatin
Sponsor
University of Wisconsin, Madison